Physician

Ronald L. Levine, M.D.

According to 2025 Medicare claims, Ronald Levine, M.D. (NPI: 1558354399) practices cardiology in the Naples-Marco Island, FL market, with the plurality of this provider's patient population coming from Collier, FL. This provider's primary affiliated billing organization is LHAW LLC (NPI: 1902145915; TIN: 800880880) and primary practice location at 34102-5616.

Levine's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,693 traditional Medicare patients, billed 20,121 HCPCS/CPT codes, and received $1,979,539 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,249 prescription claims across 690 beneficiaries totaling $343,270 in drug costs, led by Eliquis (Apixaban). 2015 DME data shows 42 claims. Open Payments data shows 35 records totaling $762. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $564,977 to $1,979,539. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $104,954 to $343,270. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,373	10,496	$564,977
2016	1,471	8,280	$648,417
2017	1,523	7,820	$598,827
2018	1,632	7,720	$660,172
2019	1,613	8,273	$905,497
2020	1,474	7,190	$899,026
2021	1,583	11,340	$1,148,512
2022	1,659	17,200	$1,597,961
2023	1,700	19,962	$2,055,326
2024	1,693	20,121	$1,979,539

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	373	1,401	$104,954
2016	403	1,411	$124,219
2017	405	1,361	$112,733
2018	570	2,253	$178,245
2019	520	1,716	$144,412
2020	494	1,667	$189,427
2021	503	1,804	$220,280
2022	545	1,935	$227,185
2023	642	2,541	$303,521
2024	690	3,249	$343,270

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	42	$3,344
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,180	1,685	$98
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	399	400	$58
99457	Management using the results of remote vital sign monitoring per calendar month, first 20 minutes	487	3,831	$41
99458	Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes	438	4,960	$33
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	1,456	1,882	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	126	9,395	$180,104
Repatha Sureclick	Evolocumab	39	1,996	$38,825
Entresto	Sacubitril/Valsartan	27	1,710	$37,966
Xarelto	Rivaroxaban	11	990	$18,097
Amlodipine Besylate	Amlodipine Besylate	371	33,207	$3,711

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	35	$762	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ronald L. Levine, M.D.?

Tedicare shows public-source Medicare data for Ronald L. Levine, M.D. (NPI 1558354399), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ronald L. Levine, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ronald L. Levine, M.D.?

Ronald L. Levine, M.D. is linked to LHAW LLC (billing NPI 1902145915) in the available physician profile data.

Does Ronald L. Levine, M.D. have Open Payments data?

Ronald L. Levine, M.D. has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.